Clinical Trial Update: Evaluating LP-10 in Subjects With OLP [Phase 2]

View source ↗

Summary

Lipella Pharmaceuticals' Phase 2 clinical trial of LP-10 for oral lichen planus is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Lichen Planus

Drugs mentioned

• LP-10 (LP-10)

Snippet

Sponsor: Lipella Pharmaceuticals, Inc. | Conditions: Oral Lichen Planus | Phase 2 | Status: ACTIVE_NOT_RECRUITING